title: [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
abstract: We investigated 361 patients with monoclonal gammopathy in whom immunoelectrophoresis was performed (1,037 tests) between 1986 and 2002 at Kagawa Prefectural Central Hospital. In this study, we identified 222 patients with monoclonal gammopathy of undetermined significance (MGUS). Malignant transformation of MGUS to multiple myeloma occurred in 15 patients (6.8%). No significant differences were observed in the means of total protein (TP), albumin (Alb), albumin/globulin ratio (A/G ratio), IgG, IgA, or IgM level in the initial examination between the patients who remained as MGUS and patients with malignant transformation of MGUS. However, the rate of progression to malignancy was high when the levels of normal immunoglobulins other than M protein were below the normal range. Since the number of MGUS cases detected and the number of protein fractionation performed were proportionate, and MGUS was found by protein fractionation in routine tests, protein fractionation is essential for detection of MGUS, and it is necessary to add serum protein fractionation to routine initial examination. In addition, long-term follow-up of patients with monoclonal gammopathy and preparation of a database of patient information are useful for monitoring the outcome.
authors.affiliation: Department of Clinical Laboratory, Kagawa Prefectural Central Hospital, Takamatsu 760-8557.
authors.forename: Masami
authors.initials: M
authors.lastname: Uchida
authors.forename: Naomi
authors.initials: N
authors.lastname: Taida
authors.forename: Mitsuko
authors.initials: M
authors.lastname: Kanao
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Kagamihara
authors.forename: Minoru
authors.initials: M
authors.lastname: Kuwajima
mesh_terms: D015415:Biomarkers / Q000097:blood; D001797:Blood Protein Electrophoresis; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D007564:Japan / Q000453:epidemiology; D009101:Multiple Myeloma / Q000453:epidemiology / Q000209:etiology; D010265:Paraproteinemias / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology; D012712:Serum Globulins / Q000032:analysis / Q000302:isolation & purification; D013997:Time Factors
chemical_list: D015415:Biomarkers; D012712:Serum Globulins